Form 8-K · Current report
Lululemon Athletica 8-K, filed Oct 22, 2026
- Filed
- CIK
- 0001397187
- Accession no.
- 0001397187-26-000135
Summary
Lululemon Athletica appointed Tara Poseley to its board of directors effective October 19, 2026, expanding the board from twelve to thirteen members, in connection with the company's May 26, 2026 cooperation agreement with founder Dennis J. "Chip" Wilson. Poseley, previously lululemon's chief product officer and CEO of Paula's Choice Skincare, will serve on the People, Culture and Compensation Committee.
Key points
- Poseley will serve as a Class II director and will receive compensation consistent with other non-employee directors.
- The board now has 13 directors, 12 of whom are independent.
- Board chair Marti Morfitt, CEO Heidi O'Neill, and founder Chip Wilson each said Poseley's product expertise would support the company's brand and product strategy.
- Poseley was CEO of Paula's Choice Skincare from 2016 to 2023 and lululemon's chief product officer from 2013 to 2015.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 5.02Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
- 7.01Regulation FD Disclosure
- 9.01Financial Statements and Exhibits
From the filing
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On October 19, 2026, the board of directors of lululemon athletica inc. appointed Tara Poseley as a member of the board of directors. Ms. Poseley was appointed in accordance with our cooperation agreement with Dennis J. "Chip" Wilson and certain of his affiliates, dated May 26, 2026. Ms. Poseley has more than 30 years of experience across specialty retail, apparel, and beauty. She most recently served as Chief Executive Officer of Paula's Choice Skincare from 2016 to 2023. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.